Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S. Maruyama H, et al. Among authors: fujimura t. Genet Med. 2019 Feb;21(2):512-515. doi: 10.1038/s41436-018-0125-2. Genet Med. 2019. PMID: 30190610 Free PMC article.
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S. Maruyama H, et al. Among authors: fujimura t. Genet Med. 2019 Jan;21(1):44-52. doi: 10.1038/gim.2018.31. Epub 2018 Mar 15. Genet Med. 2019. PMID: 29543226 Free PMC article.
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S. Maruyama H, et al. Among authors: fujimura t. Genet Med. 2019 Aug;21(8):1900. doi: 10.1038/s41436-018-0258-3. Genet Med. 2019. PMID: 30209272 Free PMC article.
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S. Maruyama H, et al. Among authors: fujimura t. Genet Med. 2019 May;21(5):1263. doi: 10.1038/s41436-019-0447-8. Genet Med. 2019. PMID: 30728527 Free PMC article.
Correction to: Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study.
Fujisawa Y, Yoshikawa S, Takenouchi T, Mori S, Asai J, Uhara H, Ichigosaki Y, Fujimura T, Nakamura Y, Nakamura Y, Ohno F, Fukumoto T, Ozawa T, Namikawa K, Sugihara S, Hoashi T, Shimauchi T, Sawada Y, Iwata H, Maeda T, Miyagawa T, Shibayama Y, Hatta N, Kishi A, Ishikawa M, Kawahira H, Katoh N, Okuyama R. Fujisawa Y, et al. Among authors: fujimura t. Int J Clin Oncol. 2025 Jun 26. doi: 10.1007/s10147-025-02814-1. Online ahead of print. Int J Clin Oncol. 2025. PMID: 40569523 No abstract available.
1,532 results